In the United States there are approximately 36,000 new cases of kidney cancer each year, and 12,000 individuals die from the disease. Kidney cancer is an international disease. New syndromes are being recognized and characterization of the associated symptoms as well as identification of the genes involved in the disease are important to develop appropriate therapies. Continuation of this project is of great importance because, at the moment, there are families with kidney cancer that do not have any of their genetic changes known. Therefore we need to study these families morphologically and genetically, as well as try to identify new proteins useful as tumor markers.
The specific aims of this study are to: 1) Define the types and morphological characteristics of new renal syndromes;2) Identify the genes and molecular changes responsible for these new syndromes;3) Identify genotype/ phenotype correlation;and 4) Study the associated lesions such as uterine and other smooth muscle tumors, skin, lung and ovarian tumors, and investigate if they share similar genetic changes. Continuation of this research is essential;first, because these tumors can only be recognized by their morphology and secondly, because we lack both markers for early detection and good forms of therapy.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Cancer Institute Division of Basic Sciences
Zip Code
Alimchandani, Meghna; Lara, Karlena; Tsokos, Maria et al. (2014) Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma. Urol Case Rep 2:39-62
Diker-Cohen, Talia; Abraham, Smita Baid; Rauschecker, Mitra et al. (2014) Reninoma presenting in pregnancy. J Clin Endocrinol Metab 99:2625-6
Kauffman, Eric C; Ricketts, Christopher J; Rais-Bahrami, Soroush et al. (2014) Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol 11:465-75
Liu, Qingyan; Galli, Susanna; Srinivasan, Ramaprasad et al. (2013) Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation. Am J Surg Pathol 37:368-74
Aung, Phyu P; Killian, Keith; Poropatich, Carrie O et al. (2013) Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy. Hum Pathol 44:873-80
Shuch, Brian; Hofmann, Jonathan N; Merino, Maria J et al. (2013) Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol :
Purdue, Mark P; Moore, Lee E; Merino, Maria J et al. (2013) An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 132:2640-7
Zhong, Minghao; Weisman, Paul; Zhu, Bing et al. (2013) Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement. Diagn Mol Pathol 22:107-11
Farley, Megan N; Schmidt, Laura S; Mester, Jessica L et al. (2013) A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res 11:1061-71
Choueiri, Toni K; Vaishampayan, Ulka; Rosenberg, Jonathan E et al. (2013) Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol 31:181-6

Showing the most recent 10 out of 13 publications